These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6393022)

  • 1. Treatment of experimental group B streptococcal infection with hybridoma antibody.
    Christensen RD; Rothstein G; Hill HR; Pincus SH
    Pediatr Res; 1984 Nov; 18(11):1093-6. PubMed ID: 6393022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis.
    Christensen RD; Shigeoka AO; Hill HR; Rothstein G
    Pediatr Res; 1980 Jun; 14(6):806-8. PubMed ID: 6995919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hybridoma antibody administration upon neutrophil kinetics during experimental type III group B streptococcal sepsis.
    Christensen RD; Rothstein G; Hill HR; Pincus SH
    Pediatr Res; 1983 Oct; 17(10):795-9. PubMed ID: 6356000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity.
    Pincus SH; Shigeoka AO; Moe AA; Ewing LP; Hill HR
    J Immunol; 1988 Apr; 140(8):2779-85. PubMed ID: 2451694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous immunoglobulin G on neutrophil kinetics during experimental group B streptococcal infection in neonatal rats.
    Harper TE; Christensen RD; Rothstein G; Hill HR
    Rev Infect Dis; 1986; 8 Suppl 4():S401-8. PubMed ID: 3092307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus.
    Shigeoka AO; Pincus SH; Rote NS; Hill HR
    J Infect Dis; 1984 Mar; 149(3):363-72. PubMed ID: 6371154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of streptococcal antigens using monoclonal antibodies.
    Harris MC; Polin RA
    Clin Lab Med; 1985 Sep; 5(3):545-60. PubMed ID: 3899481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone effects on group B streptococcal infection in newborn rats.
    Tran TV; Weisman LE
    Pediatr Infect Dis J; 2004 Jan; 23(1):47-52. PubMed ID: 14743046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-18 in experimental group B streptococcal arthritis.
    Tissi L; McRae B; Ghayur T; von Hunolstein C; Orefici G; Bistoni F; Puliti M
    Arthritis Rheum; 2004 Jun; 50(6):2005-13. PubMed ID: 15188378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease.
    Hill HR; Kelsey DK; Gonzales LA; Raff HV
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S87-91. PubMed ID: 1728992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to tumor necrosis factor-alpha: use as adjunctive therapy in established group B streptococcal disease in newborn rats.
    Givner LB; Gray L; O'Shea TM
    Pediatr Res; 1995 Oct; 38(4):551-4. PubMed ID: 8559608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating and storage neutrophils in septic neonatal rats treated with immune globulin.
    Redd H; Christensen RD; Fischer GW
    J Infect Dis; 1988 Apr; 157(4):705-12. PubMed ID: 2831286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional leukocyte administration in protection against experimental neonatal infection.
    Santos JI; Shigeoka AO; Hill HR
    Pediatr Res; 1980 Dec; 14(12):1408-10. PubMed ID: 7010290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
    Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival in the suckling rat model of group B streptococcal sepsis after treatment with nonsteroidal anti-inflammatory drugs.
    Short BL; Miller MK; Fletcher JR
    Pediatrics; 1982 Sep; 70(3):343-7. PubMed ID: 7050875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody preparations for immunotherapy of experimental GBS infection.
    Shigeoka AO; Pincus SH; Rote NS; Pritchard DG; Santos JI; Hill HR
    Antibiot Chemother (1971); 1985; 35():254-66. PubMed ID: 3901902
    [No Abstract]   [Full Text] [Related]  

  • 19. Granulocyte transfusions in septic adult and newborn rats: distribution of granulocytes and effect on peripheral blood and bone marrow.
    Baley JE; Bruce M; Stork EK; Klinger JD; Medvik K; Shurin S
    J Lab Clin Med; 1990 Mar; 115(3):283-91. PubMed ID: 2313160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
    Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
    J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.